However, the FDA label explicitly states that "it is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of GLP-1 receptor agonist-induced rodent thyroid C-cell tumors has not been determined." The rodent thyroid has substantially more C-cells than the human thyroid, and rodents may be more susceptible to this effect
acquired the data, performed analyses and prepared figures
In Phase 2 trials, participants on higher doses experienced average weight losses of more than 20% of body weight over 48 weeks, with a high proportion achieving large reductions in weight
10.1016/j.jep.2022.114997 182 Paolini PaolettiF.SimoniS.ParnettiL.GaetaniL
Furthermore, FMN is a cofactor for pyridoxine (pyridoxamine) 5-phosphate oxidase (PNPO
Peptides are stable and portable